Autoimmune neuroinflammation triggers mitochondrial oxidation in oligodendrocytes

Abstract

Oligodendrocytes (ODCs) are myelinating cells of the central nervous system (CNS) supporting neuronal survival. Oxidants and mitochondrial dysfunction have been suggested as the main causes of ODC damage during neuroinflammation as observed in multiple sclerosis (MS). Nonetheless, the dynamics of this process remain unclear, thus hindering the design of neuroprotective therapeutic strategies. To decipher the spatio-temporal pattern of oxidative damage and dysfunction of ODC mitochondria in vivo, we created a novel mouse model in which ODCs selectively express the ratiometric H 2 O 2 biosensor mito-roGFP2-Orp1 allowing for quantification of redox changes in their mitochondria. Using 2-photon imaging of the exposed spinal cord, we observed significant mitochondrial oxidation in ODCs upon induction of the MS model experimental autoimmune encephalomyelitis (EAE). This redox change became already apparent during the preclinical phase of EAE prior to CNS infiltration of inflammatory cells. Upon clinical EAE development, mitochondria oxidation remained detectable and was associated with a significant impairment in organelle density and morphology. These alterations correlated with the proximity of ODCs to inflammatory lesions containing activated microglia/macrophages. During the chronic progression of EAE, ODC mitochondria maintained an altered morphology, but their oxidant levels decreased to levels observed in healthy mice. Taken together, our study implicates oxidative stress in ODC mitochondria as a novel pre-clinical sign of MS-like inflammation and demonstrates that evolving redox and morphological changes in mitochondria accompany ODC dysfunction during neuroinflammation.

Novel recombinant protein flagellin A N/C attenuates experimental autoimmune encephalomyelitis by suppressing the ROS/NF-κB/NLRP3 signaling pathway

“…The CNS is highly vulnerable to oxidative stress due to high energy demand, mitochondrial activity, and polyunsaturated fatty acids. Hence, these features increase CNS susceptibility to typical neurodegenerative hallmarks linked with oxidative stress, which might cause CNS dysfunction in patients with MS ( Steudler et al, 2022 ). Novel fatty acid-binding protein five and seven inhibitors ameliorate glial cell injury in EAE by decreasing oxidative stress levels ( Cheng et al, 2021 ).…”

Cell-Type Specific Mitochondrial Quality Control in the Brain: A Precise Mechanism of Neurodegeneration

“…Recent large-scale epidemiological and genomic studies identified several genetic and environmental risk factors for MS. Mitochondria-targeted antioxidants SkQ1 could be promising candidates as components of a combined therapy for MS and related neurological disorders [67]. Oxidative stress in oligodendrocyte's mitochondria indicates pre-clinical sign of MS-like inflammation and demonstrates that evolving redox and morphological changes in mitochondria accompany oligodendrocyte dysfunction during neuroinflammation [68]. Another classical neurodegenerative disease in context to oligodendrocytes i.e.…”

Mitochondrial dysfunction in heart diseases: Potential therapeutic effects of Panax ginseng

“…Mitochondrial fragmentation during apoptosis is considered to be an irreversible signal in the death cascade (Green and Kroemer, 2004). Various diseases associated with heart failure, neurodegeneration, autoimmune and viral infections are mediated by mitochondria-mediated apoptosis (Schneider et al, 2019;Faccenda and Campanella, 2020;Baburina et al, 2021;Steudler et al, 2022). Programmed cell death or apoptosis is a cellular selfdestruction mechanism involving multiple biological events.…”